Optimization of adenovirus-mediated endothelial nitric oxide synthase delivery in rat hindlimb ischemia.
- Published in:
- Gene Therapy, 2005, v. 12, n. 22, p. 1640, doi. 10.1038/sj.gt.3302563
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2005 AND VI 12 AND IP 22
Results: 6
1
2
AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL.
- Published in:
- Gene Therapy, 2005, v. 12, n. 22, p. 1618, doi. 10.1038/sj.gt.3302549
- By:
- Publication type:
- Article
3
Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy.
- Published in:
- Gene Therapy, 2005, v. 12, n. 22, p. 1633, doi. 10.1038/sj.gt.3302531
- By:
- Publication type:
- Article
4
Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients.
- Published in:
- Gene Therapy, 2005, v. 12, n. 22, p. 1651, doi. 10.1038/sj.gt.3302565
- By:
- Publication type:
- Article
5
Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
- Published in:
- Gene Therapy, 2005, v. 12, n. 22, p. 1608, doi. 10.1038/sj.gt.3302581
- By:
- Publication type:
- Article
6
Gene Therapy Progress and Prospects: Fetal gene therapy – first proofs of concept – some adverse effects.
- Published in:
- Gene Therapy, 2005, v. 12, n. 22, p. 1601, doi. 10.1038/sj.gt.3302632
- By:
- Publication type:
- Article